TriangleHigh-Dose Ascorbate + Aza/Ven (NCT07177079)
High-Dose Ascorbate + Aza/Ven trial for Newly Diagnosed Acute Myeloid Leukemia (NCT07177079). This is a short film with English narration. The transcript is on this page, and the written brief is separate.
What the film says
Read the transcript
This trial is for adults with newly diagnosed acute myeloid leukemia who are not fit for intensive chemotherapy.
The idea: add high dose vitamin C, given by vein, to standard azacitidine and venetoclax. Patients are randomly assigned to standard care alone or standard care plus high dose ascorbate.
This phase 1 study plans 30 patients. It first looks at dose limiting side effects, then at complete remission rates. At the University of Iowa in Iowa City, Kittika Poonsombudlert leads it.
Public record; not medical advice.
Already in a trial?
It turns into a project to manage: visits, scans, labs, side effects and paperwork. Triangle keeps it organized in one place for you or for whoever's helping.
Organize my trial7-day free trial, then $9 a month. Cancel anytime.
How these trials work: what Phase 1 actually is · common questions Not clinical evidence.